A phase I-IIa clinical study on the investigational anticancer drug J1 in patients with advanced cancer. A prospective, single armed, open label, dose-finding phase I-IIa study

Update Il y a 4 ans
Reference: EUCTR2005-002901-22

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To define the recommended phase II dose of J1 (phase I). To confirm recommended phase II dose and investigate tumor response (phase IIa).


Inclusion criteria

  • Treatment of cancer

Links